News From The Journal Of Clinical Investigation: Nov. 14, 2011
EDITOR'S PICK: Glioblastoma multiforme in the Dock Glioblastoma multiforme (GBM) is the most common malignant brain cancer in humans. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant to current therapies. A team of researchers - led by Bo Hu and Shi-Yuan Cheng, at the University of Pittsburgh Cancer Institute, Pittsburgh - has now identified a molecular pathway that drives the aggressive cancerous nature of a substantial proportion of glioblastomas;
RCGP Says Three Quarters Of Cancer Patients Referred Within A Month, UK
According to a new report from the Royal College of General Practitioners (RCGP), in England three quarters of individuals with cancer symptoms are evaluated, examined and referred within one month of presenting their symptoms to their GP. The report, the first of its kind, is published by the RCGP's Clinical Innovation and Research Center (CIRC). The report details findings of the 2009/2010 National Audit of Cancer Diagnosis in Primary Care which was conducted as part of the National Awareness and Early Diagnosis Initiative.
Reform Required In Cancer Screening
According to a commentary published online Nov. 21 in the Journal of the National Cancer Institute, since the first guidelines on mammography screening were developed by the National Cancer Institute more than three decades ago, guidelines developed by advocacy and professional groups have focused on which individuals should be screened, rather than clearly defining the risks and benefits of screening. The commentary written by Michael Edward Stefanek, P.h.D., the associate vice president of collaborative research in the office of the vice president at Indiana University, also explains that instead of ongoing discussions regarding who should be screened, excessive time has been spent debating guidelines.